These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 22865010
1. Determination of imatinib and its active metabolite N-desmethyl imatinib in human plasma by liquid chromatography/tandem mass spectrometry. Zhang M, Moore GA, Fernyhough LJ, Barclay ML, Begg EJ. Anal Bioanal Chem; 2012 Oct; 404(6-7):2091-6. PubMed ID: 22865010 [Abstract] [Full Text] [Related]
2. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma. Zhang Y, Qiang S, Yu Z, Zhang W, Xu Z, Yang L, Wen A, Hang T. J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742 [Abstract] [Full Text] [Related]
4. Method development and validation for the simultaneous determination of imatinib mesylate and N-desmethyl imatinib using rapid resolution high performance liquid chromatography coupled with UV-detection. Tan KL, Ankathil R, Gan SH. J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov 15; 879(30):3583-91. PubMed ID: 22000961 [Abstract] [Full Text] [Related]
5. Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry. Titier K, Picard S, Ducint D, Teilhet E, Moore N, Berthaud P, Mahon FX, Molimard M. Ther Drug Monit; 2005 Oct 15; 27(5):634-40. PubMed ID: 16175138 [Abstract] [Full Text] [Related]
6. Determination of unbound fraction of imatinib and N-desmethyl imatinib, validation of an UPLC-MS/MS assay and ultrafiltration method. Arellano C, Gandia P, Lafont T, Jongejan R, Chatelut E. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct 15; 907():94-100. PubMed ID: 23000741 [Abstract] [Full Text] [Related]
8. Simultaneous quantitation of azole antifungals, antibiotics, imatinib, and raltegravir in human plasma by two-dimensional high-performance liquid chromatography-tandem mass spectrometry. Jourdil JF, Tonini J, Stanke-Labesque F. J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar 01; 919-920():1-9. PubMed ID: 23384531 [Abstract] [Full Text] [Related]
9. Simultaneous measurement of imatinib, nilotinib and dasatinib in dried blood spot by ultra high performance liquid chromatography tandem mass spectrometry. Kralj E, Trontelj J, Pajič T, Kristl A. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Aug 15; 903():150-6. PubMed ID: 22857863 [Abstract] [Full Text] [Related]
10. Use of total and unbound imatinib and metabolite LC-MS/MS assay to understand individual responses in CML and GIST patients. Streit F, Binder L, Hafke A, Brandhorst G, Braulke F, Haase D, Armbrust T, Cameron S, Ramadori G, Oellerich M, Walson P. Ther Drug Monit; 2011 Oct 15; 33(5):632-43. PubMed ID: 21912334 [Abstract] [Full Text] [Related]
11. Monitoring of imatinib targeted delivery in human leukocytes. Kralj E, Žakelj S, Trontelj J, Pajič T, Preložnik Zupan I, Černelč P, Ostanek B, Marc J, Kristl A. Eur J Pharm Sci; 2013 Sep 27; 50(1):123-9. PubMed ID: 23643738 [Abstract] [Full Text] [Related]
16. HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). D'Avolio A, Simiele M, De Francia S, Ariaudo A, Baietto L, Cusato J, Fava C, Saglio G, Di Carlo F, Di Perri G. J Pharm Biomed Anal; 2012 Feb 05; 59():109-16. PubMed ID: 22036594 [Abstract] [Full Text] [Related]